Skip to main content

Table 2 The variable at baseline and after bariatric surgery between the diabetes status of patient

From: Bile acid, glucose, lipid profile, and liver enzyme changes in prediabetic patients 1 year after sleeve gastrectomy

 

Pre-operative

1 Month

3 Months

6 Months

1 Year

Weight (Kg)

     

Pre-diabetes

107.8 ± 22.6

95.3 ± 14.3c,d,*

87.8 ± 16.7b.c,d,*

73.6 ± 7.26*

74.2 ± 6.61d,*

Diabetes

111.3 ± 23.0

94.3 ± 15.96

85.16 ± 32.3

71.96 ± 9.59

78.2 ± 11.76

Non-diabetes

99.8 ± 19.8

84.9 ± 15.01

80.13 ± 15.3

73.85 ± 18.69

67.33 ± 10.84

BMI

     

Pre-diabetes

37.5 ± 5.2

33.6 ± 4.3c,*

30.9 ± 5.02*

25.9 ± 2.48*

26.1 ± 2.53c,d,*

Diabetes

36.9 ± 4.01

33.5 ± 4.13

27.89 ± 3.99

24.46 ± 2.59

25.59 ± 3.33

Non-diabetes

36.2 ± 4.82

31.31 ± 4.15

29.21 ± 4.323

25.74 ± 3.76

25.34 ± 3.55

HbA1c (%)

     

Pre-diabetes

6.2 ± 0.79a,c

5.7 ± 0.4a,c,d,*

5.3 ± 0.3b,c,d,*

5.2 ± 0.53d,*

5.3 ± 0.2d,*

Diabetes

7.2 ± 1.14

6.4 ± 0.56

5.3 ± 0.4

4.9 ± 0.4

5.08 ± 0.3

Non-diabetes

5.39 ± 0.35

5.2 ± 0.3

5.02 ± 0.3

5.09 ± 0.27

5.09 ± 0.23

Insulin (pmol/L)

     

Pre-diabetes

26.5 ± 12.5c

13.9 ± 10.5*

10.7 ± 5.97c,d,*

7.3 ± 2.92a,*

5.7 ± 3.1b,d,*

Diabetes

23.8 ± 7.9

17.9 ± 10.99

12.05 ± 6.9

7.42 ± 5.03

6.75 ± 3.34

Non-diabetes

19.9 ± 12.3

9.3 ± 5.7

7.58 ± 4.07

11.39 ± 19.6

5.8 ± 3.11

C-peptide (ug/L)

     

Pre-diabetes

3.8 ± 1.08c

2.7 ± 1.14b,*

2.5 ± 0.91*

2.4 ± 0.85*

1.7 ± 0.49d,*

Diabetes

4.39 ± 2.74

4.08 ± 1.68

2.75 ± 0.98

2.3 ± 0.99

1.97 ± 0.67

Non-diabetes

3.25 ± 1.31

2.44 ± 1.07

2.17 ± 0.82

2.4 ± 2.5

1.6 ± 0.6

Glucose (mmol/l)

     

Pre-diabetes

5.9 ± 1.03a,c

5.12 ± 0.66a,d,*

5.1 ± 0.71b,c,d,*

5.1 ± 1.08d,*

4.9 ± 0.37b,d,*

Diabetes

8.3 ± 2.67

6.2 ± 1.26

5.52 ± 0.81

5.3 ± 0.36

4.7 ± 0.46

Non-diabetes

5.08 ± 0.53

4.96 ± 0.51

4.9 ± 0.47

4.9 ± 0.51

4.74 ± 0.39

TBA (umol/L)

     

Pre-diabetes

4.3 ± 4.07

3.08 ± 2.37

2.3 ± 1.56

2.04 ± 0.87a,b,*

1.93 ± 0.65*

Diabetes

3.77 ± 2.2

2.6 ± 1.11

2.8 ± 1.57

4.33 ± 1.71

3.74 ± 3.0

Non-diabetes

4.06 ± 4.69

3.47 ± 3.43

2.57 ± 2.79

4.36 ± 7.28

2.64 ± 1.79

CHOL (mmol/L)

     

Pre-diabetes

5.1 ± 0.99

4.48 ± 0.9

4.7 ± 0.67

5.2 ± 0.76

5.06 ± 0.72

Diabetes

5.2 ± 1.47

4.62 ± 0.39

4.83 ± 0.84

4.9 ± 0.7

4.71 ± 0.77

Non-diabetes

4.9 ± 0.89

4.37 ± 0.83

4.84 ± 0.87

4.9 ± 0.99

4.87 ± 0.81

TG (mmol/L)

     

Pre-diabetes

2.3 ± 2.21

1.31 ± 0.41*

1.27 ± 0.35*

1.12 ± 0.25c,*

0.75 ± 0.19*

Diabetes

2.23 ± 1.06

1.8 ± 1.05

1.11 ± 0.29

1.17 ± 0.65

0.83 ± 0.19

Non-diabetes

1.71 ± 0.91

1.2 ± 0.42

1.11 ± 0.41

0.86 ± 0.23

0.86 ± 0.36

LDL (mmol/L)

     

Pre-diabetes

3.2 ± 0.68

2.75 ± 0.78

3.06 ± 0.56

3.4 ± 0.58c

2.82 ± 0.43

Diabetes

3.5 ± 0.97

3.1 ± 0.34

3.04 ± 0.57

2.92 ± 0.76

2.7 ± 0.53

Non-diabetes

3.02 ± 0.74

2.73 ± 0.64

3.0 ± 0.69

2.93 ± 0.71

2.78 ± 0.51

HDL (mmol/L)

     

Pre-diabetes

0.99 ± 0.22c

1.05 ± 0.8

1.0 ± 0.22

1.18 ± 0.21*

1.38 ± 0.17*

Diabetes

1.0 ± 0.16

0.87 ± 0.18

1.09 ± 0.28

1.16 ± 0.3

1.27 ± 0.27

Non-diabetes

1.1 ± 0.29

0.97 ± 0.18

1.09 ± 0.21

1.27 ± 0.24

1.39 ± 0.25

ALT (U/L)

     

Pre-diabetes

69.2 ± 41.2c

48.6 ± 23.2c

26.2 ± 13.59c,d,*

15.3 ± 6.67d,*

12.86 ± 5.13*

Diabetes

74.4 ± 47.2

55.87 ± 32.64

31.21 ± 18.09

21.2 ± 11.76

18.9 ± 9.43

Non-diabetes

41.7 ± 40.89

34.1 ± 26.43

18.23 ± 11.56

18.77 ± 15.73

14.69 ± 5.31

AST (U/L)

     

Pre-diabetes

40.0 ± 22.7c

38.6 ± 17.96c

21.9 ± 8.52d,*

18.02 ± 9.62d,*

17.9 ± 4.06*

Diabetes

45.1 ± 26.8

38.9 ± 19.8

25.28 ± 9.19

18.8 ± 8.55

18.1 ± 5.51

Non-diabetes

26.8 ± 18.59

26.9 ± 12.45

20.51 ± 16.24

18.63 ± 12.23

16.94 ± 3.68

  1. *P≤ 0.05 versus pre-operative within pre-diabetes group
  2. aP≤ 0.05 Pre-diabetes versus diabetes at the same time point
  3. bP≤ 0.05 The change of concentration between pre-diabetes and diabetes
  4. cP≤ 0.05 Pre-diabetes versus non-diabetes at the same time point
  5. dP≤ 0.05 The change of concentration between pre-diabetes and non-diabetes